Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2Genitourinary 2

Conditions

Vulvar Neoplasms 1Postoperative Complications 1Neoplasms 1Lymphedema 1Endometrial Neoplasms 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 134pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Letrozole 28Drug Therapy 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23durvalumab 22Albumin-Bound Paclitaxel 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20Specimen Handling 20Filgrastim 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Lymph Node Excision × Gynecologic × Clear all
NCT01512810 2021-11-24

Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer

University of Kentucky

Phase 2 Completed
200 enrolled
Gynecologic

Neoplasms, Endometrial Neoplasms

NCT01406769 2021-05-07

Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

GOG Foundation

Phase 2 Completed
120 enrolled
Gynecologic

Lymphedema, Postoperative Complications, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡